Two Healthcare Stocks I'm Watching Now - 3-Minute Stock Analysis
Up Next
8 videosShould you buy Apple stock? (September 2023)
September 13th, 2023
Celsius Stock Analysis (November 2023)
November 19th, 2023
Should you buy The Trade Desk stock? (November 2023)
November 15th, 2023
Should you buy Chewy stock? (July 2024)
July 11th, 2024
Should you buy Adyen stock? (August 2024)
August 27th, 2024
Snowflake stock analysis #shorts
December 1st, 2022
Should you buy Goldman Sachs stock? (November 2024)
November 11th, 2024
State Of The Stock Market - April 2025
April 5th, 2025
Published first at https://www.3minutebreakdowns.com Two healthcare stocks I'm watching now. Dutch biotech company Uniqure soared over 300% in September after releasing data that showed positive results for its treatment of Huntington’s disease. Uniqure’s experimental gene therapy is delivered directly into the brain and the company’s 3 year study showed a 75% slowing progression of the devastating disease. The news was greeted with euphoria and hailed as a stunning breakthrough by the scientific community. And the therapy could also be highly lucrative for Uniqure with gene therapy treatments often costing upwards of 2 millions dollars. However, on November 3rd, Uniqure stock gave back almost all its gains as it emerged the FDA would no longer accept the company’s data as robust enough to support a BLA submission. Investors scaled back their bets as a new study could take years to develop. ABOUT ME Joe is the original founder of 3-minute Breakdowns and editor for Overlooked Alpha, the number one newsletter for overlooked investing ideas and stock market analysis. Joe evaluates companies from a business-first perspective, searching for things that the market has got wrong and waiting for the 'fat pitch'. LINKS My website: https://www.3minutebreakdowns.com/ Koyfin charts: https://www.koyfin.com/affiliate/overlooked-alpha/?via=3mb TikTok: https://www.tiktok.com/@overlookedalpha X: https://x.com/OverlookedAlpha DISCLAIMER & DISCLOSURE This content is for educational and entertainment purposes only. 3-Minute Breakdowns is not a registered investment advisor and does not provide financial recommendations (only opinions). The information is being presented without consideration of the investment objectives, risk tolerance, or financial circumstances of any specific investor and might not be suitable for all investors. Past performance is not indicative of future results. All investing involves risk, including the possible loss of principal. The author reserves the right to buy and sell or change his position in a particular stock at any time. This description contains affiliate links that allow you to find the items that I personally use and recommend. Thank you for your support.
